|
Infusion criteria | Patients planning pancreaticoduodenectomy
/Age between 18-75
/The heart and lung functions were basically sound without obvious organic diseases
/Good compliance
/Agree and sign the informed consent form for the operation
|
|
Exclusion criteria | |
|
Enrollment | BCID group
|
|
Date | 2022-1-17 |
|
Age | 59 |
|
Sex | Male
|
|
BMI index | 27.1 kg/㎡ |
|
Smoking | No
|
|
Alcohol Consumption | No
|
|
Diabetes or not | Yes
|
|
Total protein | 67.3 g/L |
|
Albumin | 29.1 g/L |
|
Total bilirubin | 3.3 μmol/L |
|
prothrombin time | 11.5 s |
|
Hemoglobin content | 124 g/L |
|
Reducing jaundice or not before operation | No
|
|
Position of the tumor | 胰头 |
|
Diameter of main pancreatic duct | 1.92 mm |
|
Operation time | 325 min |
|
Intraoperative blood loss | 200 ml |
|
Pancreatic texture | Yes
|
|
Pancreticojejunostomy time | 8 min |
|
Blood transfusion volume | 1 u |
|
Converted to open pancreaticoduodenectomy | No
|
|
Classificaiton of POPF | No pancreatic fistula
|
|
Drainage tube removal time | 11 d |
|
Pathological type | 导管腺癌 |
|
Postoperative bleeding or not | No
|
|
Nasogastric decompression time | 6 d |
|
Gastric emptying disorder or not | No
|
|
Pulmonary infection or not | No
|
|
Abdominal infection or not | No
|
|
Biliary leakage | No
|
|
Reoperation or not | No
|
|
Postoperative hospital stay | 15 d |
|
Hospitalization expenses | 116141 yuan |
|
Postoperative mortality | No
|
|
90-Day readmission | No
|